Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis

. 2017 Jan 23;2017(1):CD004753. doi: 10.1002/14651858.CD004753.pub4

Study	Reason for exclusion
Cobellis 2004	This trial assessed use of the cyclo‐oxygenase (COX)‐2‐specific inhibitor (rofecoxib) for management of pain related to endometriosis. However, this drug was withdrawn from the marketplace in November 2004 on safety grounds; therefore, it is inappropriate to assess the efficacy of the product in this review. If the drug is re‐launched, we will review this decision at the time the review would be updated.

Study

Reason for exclusion

Cobellis 2004

This trial assessed use of the cyclo‐oxygenase (COX)‐2‐specific inhibitor (rofecoxib) for management of pain related to endometriosis. However, this drug was withdrawn from the marketplace in November 2004 on safety grounds; therefore, it is inappropriate to assess the efficacy of the product in this review. If the drug is re‐launched, we will review this decision at the time the review would be updated.